Skip to main content
OpenTrials

Clinical trial condition

Migraine Disorders

Explore clinical trials studying Migraine Disorders. Study availability and eligibility vary by location and protocol.

1,130 public trials 139 recruiting studies
Refine in advanced search Browse all conditions

Migraine Disorders trial results

Completed

Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine

NCT03832998

Conditions
Brain Diseases, Central Nervous System Diseases, Headache, +9 more
Locations
  • Paradigm Clinical Research Center Inc San Diego, California, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
  • New England Institute for Clinical Research Stamford, Connecticut, United States
View all 101 locations
View Trial Details
Completed

Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine

NCT04921384

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • The First Medical Center of The Chinese PLA General Hospital (301 Hospital) Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Guangzhou Medical University - Yanjiang Campus Guangzhou, Guangdong, China
  • People's Hospital of Zhengzhou Zhengzhou, Henan, China
  • Renmin Hospital of Wuhan University - Main Campus Wuhan, Hubei, China
View all 87 locations
View Trial Details
Completed

A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.

NCT05810038

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • The Second People's hospital of Hefei Hefei, Anhui, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • The fourth people's hospital of chongqing Chongqing, Chongqing Municipality, China
View all 49 locations
View Trial Details
Completed

Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan

NCT05064371

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • DOI Clinic Internal Medicine Hiroshima-Shi Naka-Ku, Hiroshima, Japan
  • Jinnouchi Neurosurgery Clinic Kasuga-Shi, Hukuoka, Japan
  • Ikeda Neurosurgical Clinic Kasuga-Shi, Hukuoka, Japan
  • Mito Kyodo General Hospital Mito, Ibaraki, Japan
View all 17 locations
View Trial Details
Completed

A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age

NCT04464707

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • Teva Investigational Site 14281 Little Rock, Arkansas, United States
  • Teva Investigational Site 14253 Banning, California, United States
  • Teva Investigational Site 14370 Loma Linda, California, United States
  • Teva Investigational Site 14322 Los Angeles, California, United States
View all 89 locations
View Trial Details
Completed

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

NCT05217927

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • AMR Clinical Tempe, Arizona, United States
  • Axiom Research, Llc Colton, California, United States
  • Clinical Research Institute Los Angeles, California, United States
  • Wr-Pri, Llc Newport Beach, California, United States
View all 107 locations
View Trial Details

Related conditions